Paid Clinical Trials in Oregon

Oregon has 1,289 paid clinical trials enrolling now across cities including Portland, Eugene and Newberg. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

1,289 clinical trials

↓ Download CSV

School-based Paraeducator Education for Engagement at Recess

for Autism Spectrum Disorder

3 locations incl. Los Angeles

Sponsor: University of Washington

Sex: All·Age: 5+·Accepts healthy volunteers

Code: NCT06559267·Recruiting

Apply to this trial

Clinical Trial: Rapid Immune Modulating Effects

for Immune Surveillance

1 location in Klamath Falls

Sponsor: Natural Immune Systems Inc

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT07195552·Recruiting

Apply to this trial

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

for Rectal Cancer

101 locations incl. Phoenix

Sponsor: Canadian Cancer Trials Group

Sex: All·Age: 18+

Code: NCT06205485·Phase 3·Recruiting

Apply to this trial

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

for Castration Resistant Prostate Cancer

1 location in Portland

Sponsor: OHSU Knight Cancer Institute

Sex: Male·Age: 18+

Code: NCT05919329·Phase 4·Recruiting

Apply to this trial

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for Transthyretin Amyloidosis

30 locations incl. La Jolla

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06465810·Recruiting

Apply to this trial

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

for Head and Neck Squamous Cell Carcinoma

Drug: Petosemtamab

61 locations incl. Mobile

Sponsor: Merus B.V.

Sex: All·Age: 18+

Code: NCT06496178·Phase 3·Recruiting

Apply to this trial

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

for Acute Respiratory Distress Syndrome

33 locations incl. Tucson

Sponsor: Beth Israel Deaconess Medical Center

Sex: All·Age: 18+

Code: NCT06066502·Phase 3·Recruiting

Apply to this trial

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

for Advanced Esophageal Adenocarcinoma

Drug: Nivolumab

371 locations incl. Little Rock

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06203600·Phase 2, Phase 3·Recruiting

Apply to this trial

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for Triple-Negative Breast Cancer

88 locations incl. Mobile

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06393374·Phase 3·Recruiting

Apply to this trial

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

for Atrial Fibrillation

1 location in Portland

Sponsor: OHSU Knight Cancer Institute

Sex: All·Age: 18+

Code: NCT06067438·Phase 2·Recruiting

Apply to this trial

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

for Prostate Adenocarcinoma

7 locations incl. Chicago

Sponsor: Alessa Therapeutics Inc.

Sex: Male·Age: 21+

Code: NCT06257693·Phase 1·Recruiting

Apply to this trial

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

for Cardiovascular

7 locations incl. Jacksonville

Sponsor: CRISPR Therapeutics AG

Sex: All·Age: 18 - 75

Code: NCT07491172·Phase 1·Recruiting

Apply to this trial

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

for Glioblastoma

Drug: Niraparib

32 locations incl. Birmingham

Sponsor: Ivy Brain Tumor Center

Sex: All·Age: 18+

Code: NCT06388733·Phase 3·Recruiting

Apply to this trial

Evaluation of the Patellar LIFT System for Subjects With Patellofemoral Cartilage Degeneration

for Patellofemoral Osteoarthritis

5 locations incl. La Mesa

Sponsor: ZKR Orthopedics Inc

Sex: All·Age: 22 - 65

Code: NCT06423300·Recruiting

Apply to this trial

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for Acute Myeloid Leukemia

335 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05564390·Phase 2·Recruiting

Apply to this trial

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for Large B-cell Lymphoma

60 locations incl. Gilbert

Sponsor: Allogene Therapeutics

Sex: All·Age: 18+

Code: NCT06500273·Phase 2·Recruiting

Apply to this trial

Essential Amino Acid Supplementation for Femoral Fragility Fractures

for Femoral Fracture

2 locations incl. Iowa City

Sponsor: Michael C Willey

Sex: All·Age: 65+

Code: NCT06050668·Phase 2·Recruiting

Apply to this trial

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

for Diabetes Mellitus, Type 1

60 locations incl. Scottsdale

Sponsor: vTv Therapeutics

Sex: All·Age: 18+

Code: NCT06334133·Phase 3·Recruiting

Apply to this trial

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

for Atopic Dermatitis

Drug: Upadacitinib

83 locations incl. Birmingham

Sponsor: AbbVie

Sex: All·Age: 18 - 63

Code: NCT06389136·Phase 3·Recruiting

Apply to this trial

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

for Diffuse Large B-Cell Lymphoma

Drug: Mosunetuzumab

1 location in Portland

Sponsor: OHSU Knight Cancer Institute

Sex: All·Age: 18 - 75

Code: NCT06249191·Phase 1, Phase 2·Recruiting

Apply to this trial

Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation

for Mild Traumatic Brain Injury, Concussion

3 locations incl. Portland

Sponsor: Oregon Health and Science University

Sex: All·Age: 18 - 60

Code: NCT06381674·Recruiting

Apply to this trial

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

for Stargardt Disease

10 locations incl. San Francisco

Sponsor: Ascidian Therapeutics, Inc

Sex: All·Age: 12+

Code: NCT06467344·Phase 1, Phase 2·Recruiting

Apply to this trial

IVIG for Infection Prevention After CAR-T-Cell Therapy

for Hematologic Malignancies

7 locations incl. Duarte

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT05952804·Phase 2·Recruiting

Apply to this trial

Evaluation of the Typical Spinal Block During Cesarean Delivery

for Cesarean Section

1 location in Portland

Sponsor: Oregon Health and Science University

Sex: Female·Age: 15 - 55

Code: NCT06206044·Enrolling By Invitation

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

for Atopic Dermatitis

15 locations incl. Birmingham

Sponsor: LEO Pharma

Sex: All·Age: 6 Months - 11

Code: NCT06311682·Phase 3·Recruiting

Apply to this trial

CREATE: Art for Children With Cancer

for Hematopoietic and Lymphatic System Neoplasm

1 location in Portland

Sponsor: OHSU Knight Cancer Institute

Sex: All·Age: 8 - 13

Code: NCT06342453·Recruiting

Apply to this trial

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

for Prostate Cancer

12 locations incl. New Haven

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Male·Age: 18+

Code: NCT06457919·Phase 1, Phase 2·Recruiting

Apply to this trial

A Clinical Study of YL205 in Patients With Advanced Solid Tumors

for Advanced Solid Tumors

11 locations incl. Denver

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All·Age: 18+

Code: NCT06459973·Phase 1, Phase 2·Recruiting

Apply to this trial

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for Myelofibrosis

Drug: Ruxolitinib

58 locations incl. Birmingham

Sponsor: Kartos Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06479135·Phase 3·Recruiting

Apply to this trial

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

for High-Risk Prostate Cancer

6 locations incl. West Los Angeles

Sponsor: VA Office of Research and Development

Sex: Male·Age: 18+

Code: NCT05593497·Phase 2·Recruiting

Apply to this trial

A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

for Leukemia, Lymphocytic, Chronic, B-Cell

Drug: Ibrutinib

32 locations incl. Cerritos

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05963074·Phase 2·Recruiting

Apply to this trial

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

for Cystic Fibrosis

18 locations incl. Birmingham

Sponsor: University of Pittsburgh

Sex: All·Age: 18+

Code: NCT06296394·Recruiting

Apply to this trial

Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device

for Degenerative Conditions of the Lumbar Spine

6 locations incl. Newnan

Sponsor: Spinal Simplicity LLC

Sex: All·Age: 18+

Code: NCT06355791·Recruiting

Apply to this trial

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

for AML With Gene Mutations

12 locations incl. Los Angeles

Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All·Age: 18+

Code: NCT06366789·Phase 1·Recruiting

Apply to this trial

A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

for Pediatric

Drug: Aficamten

26 locations incl. Phoenix

Sponsor: Cytokinetics

Sex: All·Age: 12 - 17

Code: NCT06412666·Phase 2, Phase 3·Recruiting

Apply to this trial

Impella RP Flex with Smart Assist

for Right Ventricular (RV) Dysfunction

31 locations incl. Birmingham

Sponsor: Abiomed Inc.

Sex: All·Age: All ages

Code: NCT06637644·Recruiting

Apply to this trial

First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors

for Select Advanced Solid Tumors

4 locations incl. Miami

Sponsor: CDR-Life AG

Sex: All·Age: 18+

Code: NCT06402201·Phase 1·Recruiting

Apply to this trial

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer

22 locations incl. Birmingham

Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All·Age: 18+

Code: NCT06343402·Phase 1·Recruiting

Apply to this trial

PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC

for Head and Neck Squamous Cell Carcinoma

Drug: Rilvegostomig

7 locations incl. Sacramento

Sponsor: Presage Biosciences

Sex: All·Age: 18+

Code: NCT06366451·EARLY_Phase 1·Recruiting

Apply to this trial

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

for Small Cell Lung Cancer

30 locations incl. Springdale

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06203210·Phase 3·Recruiting

Apply to this trial